Navigation Links
Interleukin Genetics President and Chief Scientific Officer to Present at Immunotoxicology V Conference
Date:9/17/2007

lcontent.com/Engine?Account=prnewswire&PageName=QUOTE&Ticker=ILI" onClick="var s=s_gi(s_account); var hd1 = document.getElementById('headline'); s.tl(this,'o',getLinkName('Company Sanpshot'));" >ILI) is a genetics-focused personalized health company that develops preventive consumer products and genetic tests for sale to the emerging personalized health market. Focused on the future of health and medicine, Interleukin uses its leading genetics research and scientific capabilities to develop and test innovative preventive and therapeutic products. Interleukin currently offers an array of Nutraceuticals and OTCeuticals, including Ginkoba(R), Ginsana(R) and Venastat(R) which are sold at the nation's largest food, drug and mass retailers, and has commercialized genetic tests for periodontal disease risk assessment, cardiovascular risk assessment, and general nutrition assessment. Interleukin is headquartered in Waltham, MA. For more information about Interleukin and its ongoing programs, please visit http://www.ilgenetics.com.

Certain statements contained herein are "forward-looking" statements including statements regarding our ability to develop diagnostic, personalized nutritional and therapeutic products to prevent or treat diseases of inflammation and other genetic variations, our ability to screen nutritional compounds for their effects on inflammatory responses and other genetic variations, given specific genetic patterns and our ability to make progress in advancing our core technologies. Because such statements include risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward- looking statements include, but are not limited to, the risk of market acceptance of our products, the risk of technology and product obsolescence
'/>"/>

SOURCE Interleukin Genetics
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Wisconsin court affirms damages in Innogenetics, Abbott patent case
2. Third Wave licenses Innogenetics tech to settle lawsuit
3. Symposium examines the effect of race on genetics and disease
4. Siemens health services president calls IT benefits unassailable
5. Wisconsin IT association names Gee president, CEO
6. Merge Healthcare promotes Bowers to president
7. Quintessence Biosciences names new president
8. VanderSanden appointed president of AT&T Wisconsin
9. Merge president steps down in wake of shareholder suits
10. Milwaukees PointOne appoints new president and CEO
11. Cars.com president slated for Milwaukee event
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)...Dec. 3 ACCESS PHARMACE...y provided an update on its European commercial la... mucositis, a debilitating side effect of radiatio...ly launched by Access, partner, SpePharm, in six E...y, Norway, Greece and Sweden. Access is conducting...
(Date:12/3/2009)...ass., Dec. 3 Caliper Lif...der of tools and services for drug discovery and l...ge 4.0 software for IVIS® in vivo imaging sys...00 Caliper IVIS systems currently installed in lab...anced spectral unmixing tools to enhance fluoresce...
(Date:12/2/2009)...K, Dec. 2 Reportlinker.com announc...in its catalogue: ,, Carbondioxide Incubators ...eportlinker.com/p0164368/Carbondioxide-Incubators-...ors are the most critical equipment used in microb...ications for providing a controlled environment to...
(Date:12/2/2009)..., Dec. 2 /PRNewswire-FirstCall/ - Oncolytics Biote...NASDAQ: ONCY ) announced today that in connection ...nderwriters have exercised in full their over-allo...nits. Each unit is comprised of one common share a... sold at a price of US$3.00 per unit. Each whole c...
Breaking Biology Technology:Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4Caliper Life Sciences Launches Living Image(R) 4.0 Software 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4
...oday announced the,publication of an independent, ...e level of cellular immune response measured prior...prietary ImmuKnow(R) immune cell,function test was...r early,acute transplant rejection and unstable ki...transplantation., The results of this independent...
...ard a U.S. Naval Academy satellite called MidSTAR-...One technology is a sensor that can check for harm...at can control heat. , These technologies were co...e Flight Center, Greenbelt, Md.; NASAs Ames Resear...gy Systems Inc. of various U.S. locations, respect...
...& Lione, one of,the largest intellectual property ...unce that Meredith Martin Addy has been named one ...actice areas by Law & Politics,magazine., Intelle...tionally has,been dominated by men. However, in fo...st recognized patent attorneys in Illinois. In the...
Other Biology Technology:New Independent Research Study Indicates That Cylex's ImmuKnow Test May Identify Kidney Transplant Patients at Risk for Early Acute Rejection 2New Independent Research Study Indicates That Cylex's ImmuKnow Test May Identify Kidney Transplant Patients at Risk for Early Acute Rejection 3NASA MidSTAR-1 successful technologies may be revolutionary 2NASA MidSTAR-1 successful technologies may be revolutionary 3NASA MidSTAR-1 successful technologies may be revolutionary 4Meredith Martin Addy Named One of Top 10 Illinois 'Super Lawyers' for 2008 2
(Date:12/2/2009)...dhand smoke for a prolonged period of time and in ...er, even in women who never smoked cigarettes them...side-stream smoke could increase risk of breast ca...ds, Ph.D., senior research scientist at the Northe...ile no single epidemiologic study can answer the q...
(Date:12/2/2009)...tter, and other foods have done more than raise pu... also are quietly fueling a boom in the market for...ety regulations. That,s the topic of the two-part ...gineering News , (C&EN) ACS, weekly newsmagazine. ...or Correspondent Marc Reisch point out that food s...
(Date:12/2/2009)...al Center researchers have figured out how stem ce...tter able to resist radiation therapy. And using a...hese cancer stem cells, they were able to kill man... experiment. , The work builds off earlier rese...e effects of radiation much better than other canc...
Breaking Biology News(10 mins):Exposure to secondhand cigarette smoke over a lifetime increased breast cancer risk later in life 2Discovery makes brain tumor cells more responsive to radiation 2Stemedica Completes Meeting with the FDA 14477 1Stemedica Completes Meeting with the FDA 14477 2Stemedica Completes Meeting with the FDA 14477 3deVere and Partners Raises Funds for Geneva Children in Need 59509 1deVere and Partners Raises Funds for Geneva Children in Need 59509 2deVere and Partners Raises Funds for Geneva Children in Need 59509 3New ALS Patient Simulator Advanced Provides Valuable Training for EMS Teams and In Hospital Emergency Personnel 5499 1New ALS Patient Simulator Advanced Provides Valuable Training for EMS Teams and In Hospital Emergency Personnel 5499 2
...ified another anti-cancer effect of the "longevity...e tumor promoter c-Myc, SIRT1 curbs cell division.....jcb.org ) and will appear in the April 20 print i...st and nematode equivalents of SIRT1 are fountains...ws aging in mammals isn,t certain, but it,s benefi...
...human and mouse, two groups of researchers have co... is associated with progressive hearing loss. The ...of RNA that affects the production of hundreds of ...nner ear. , The research provides important new ...n in humans but remains poorly understood. , One ...
...ntially catastrophic damage, for example as a resu...ke a decision: either to fix the damage or program... , It,s a stark decision that is as mysterious a...bed metaphorically as a network of internal alarms...ell nucleus. In intricate ways, cells orchestrate...
Other Biology News:New insights into progressive hearing loss 2New insights into progressive hearing loss 3New insights into progressive hearing loss 4CSHL-led team identifies key decision-point at which cells with broken DNA repair themselves or die 2CSHL-led team identifies key decision-point at which cells with broken DNA repair themselves or die 3CSHL-led team identifies key decision-point at which cells with broken DNA repair themselves or die 4
Eppendorf Thermomixer R from Eppendorf North America
BD BioCoat Laminin 35 mm Culture Dishes from BD Biosciences - Discovery Labware
BD BioCoat Matrigel Matrix 35 mm Culture Dishes from BD Biosciences - Discovery Labware
BD BioCoat Fibronectin 35 mm Culture Dishes from BD Biosciences - Discovery Labware
Biology Products: